Carta and NewView partner, hoping to entice more startups to let employees sell shares early

NewView and Carta partnered to streamline employee tender offers, which let employees and sometimes early investors sell a portion of their shares to approved buyers. Their study projects tender offers at Series C and later-stage startups will increase threefold over three years, though only 44 were executed in the first half of 2026. NewView says tenders can support employee retention as startups remain private for 12 to 15 years; its firm led a tender for HighTouch at a $1.3 billion valuation.

Analysis

The investable signal is less “more liquidity” than a potential shift in how private-company equity compensation is financed. A repeatable tender process could reduce the retention discount employees apply to illiquid options and help late-stage firms compete with public-company compensation. But liquidity is not free: company-funded tenders can consume cash that otherwise supports growth, while investor-funded tenders transfer shares without improving the company’s balance sheet. If employees sell and then leave anyway, the retention case weakens; if tenders become routine, buyers may demand larger discounts and employees may anchor on tender prices as a de facto valuation.

For private-market infrastructure providers such as Carta and secondary-market operators such as Forge Global, the opportunity is workflow volume, but the article’s low absolute execution count argues against extrapolating the growth rate into near-term material revenue. NewView is a private investment firm, not a liquid public-market proxy. Over 1–3 months, watch for actual tender frequency, buyer participation, discount to the latest financing, and whether issuers or outside investors fund transactions. Over 6–18 months, the structural test is whether liquidity improves retention without encouraging employee selling or distracting management. The contrarian risk: tenders can make prolonged private status more tolerable for employees and investors, potentially delaying IPO supply rather than creating a path to public listings. The thesis weakens if execution stays sporadic, discounts widen, or companies report no improvement in retention.

Key Decisions for Investors

• No direct public-equity trade is justified from this evidence alone: Carta and NewView are not identified as publicly traded companies, and the reported activity remains small in absolute terms.
• Add Carta and Forge Global to a watchlist, not a buy list. Reassess only with evidence that completed tenders are recurring, monetizable workflows—not simply announcements—and that buyer demand is broad enough to avoid widening discounts.
• For late-stage private-company exposure, treat employee tenders as a liquidity and retention signal, not proof of stronger fundamentals. Verify who funds the offer, the discount to the latest financing, participation rates, and whether the company’s cash is used.
• Falsification / catalyst checklist for the next 1–3 quarters: tender execution fails to scale, secondary bids weaken relative to private marks, or retention metrics do not improve. Conversely, repeated third-party-funded tenders at modest discounts would strengthen the infrastructure-volume thesis.